SUBSCRIBE
SUBSCRIBE
News   Policy

RepRegen™ Ltd. (Formerly Known as BioCeramic Therapeutics) Seeks US FDA 510(k) Clearance for StronBone(TM)

February 9, 2011 | 
1 min read
LONDON--(BUSINESS WIRE)--RepRegen, the ‘smart biomaterials’ company, announced today that RepRegen Inc. in the US has submitted StronBone to the U.S. FDA for 510(k) clearance.
Regulatory Europe
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Holds tickets in hand, isolated on white background. Vector flat. stock illustration
Regulatory
FDA Hands Out First Commissioner’s Priority Vouchers to Regeneron, Sanofi, Disc, Others
October 17, 2025
 · 
2 min read
 · 
Tristan Manalac
Health saving account, HSA, financial plan saving for medical expense or medicare cost and benefits concept, doctor with stethoscope standing with huge pink piggy bank or coin bank with medical sign.
Drug pricing
In Affordability Push, EMD Serono Joins TrumpRx While Roche Launches DTC Program
October 17, 2025
 · 
2 min read
 · 
Tristan Manalac
Human resource management and recruitment concept. Job rotation or staff turnover icon.
Government
FDA’s Orphan Drug Director Out Amid IRA Exemption Rollout
October 16, 2025
 · 
2 min read
 · 
Tristan Manalac
Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
Gene therapy
FDA’s Second Platform Designation Goes to Krystal After Sarepta Withdrawal
October 15, 2025
 · 
2 min read
 · 
Tristan Manalac